Tranilast alleviates skin inflammation and fibrosis in rosacea-like mice induced by long-term exposure to LL-37
- 8 August 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 737, 150523
Abstract
No abstract availableKeywords
Funding Information
- Hebei Province Medical Science Research Key Project (20221534)
This publication has 33 references indexed in Scilit:
- Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stabilityInternational Journal of Pharmaceutics, 2023
- Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+/CaMKII-mTOR-NF-κB activationBiomedicine & Pharmacotherapy, 2022
- In vitro and vivo study of tranilast protects from acute respiratory distress syndrome and early pulmonary fibrosis induced by smoke inhalationBurns, 2022
- Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in miceEBioMedicine, 2021
- Anti-cancer effects of Tranilast: An updateBiomedicine & Pharmacotherapy, 2021
- Aspirin alleviates skin inflammation and angiogenesis in rosaceaInternational Immunopharmacology, 2021
- Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel diseaseBiomedicine & Pharmacotherapy, 2021
- TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunitiesThe Journal of Pathology, 2021
- TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signalingCellular and Molecular Life Sciences, 2020
- Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cellsAtherosclerosis, 1994